Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abhijit Debnath

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Scientific Reports|August 19, 2025
Unlocking the antimalarial potential of novel steroid-tetraoxane hybrids through consensus molecular docking and molecular dynamics investigationDipankar Nath, Abhijit Debnath, Malita Sarma, et al.
Plos One|April 22, 2026
In search of novel PD1 inhibitor from natural products by high-throughput virtual screening and molecular dynamics simulationNeha Sharma, Abhijit Debnath, Rupa Mazumder, et al.
Bioorganic Chemistry|May 18, 2025
Design, synthesis, docking, DFT, and MD simulation studies of new piperazine, 1,3,4-oxadiazole, and quinoline conjugates: A search for potent antiepileptic agentsShrishti Tripathi, Rajnish Kumar, Abhijit Debnath, et al.
Bioorganic Chemistry|June 3, 2025
Corrigendum to "Design, synthesis, docking, DFT, and MD simulation studies of new piperazine, 1,3,4-oxadiazole, and quinoline conjugates: A search for potent antiepileptic agents" [Bioorg. Chem. 162 (2025) 108595]Shrishti Tripathi, Rajnish Kumar, Abhijit Debnath, et al.
Current Pharmaceutical Biotechnology|July 2, 2025
Challenges and Progress of Orphan Drug Development for Rare DiseasesAbhijit Debnath, Rupa Mazumder, Avijit Mazumder, et al.
Scientific Reports|August 28, 2025
Author Correction: Discovery of novel HBV core protein inhibitors by high throughput virtual screeningJahanvi Sanchitra, Abhijit Debnath, Anil Kumar Singh, et al.
Current Pharmaceutical Biotechnology|November 2, 2025
Novel Drug Molecules for Atherosclerosis from Ginkgo biloba, an Endangered Himalayan Herb, Via Pharmacoinformatics ApproachesShiwani Chahal, Abhijit Debnath, Pooja Ridhal, et al.
Scientific Reports|April 16, 2025
Discovery of novel HBV core protein inhibitors by high throughput virtual screeningJahanvi Sanchitra, Abhijit Debnath, Anil Kumar Singh, et al.
Journal of Basic Microbiology|April 3, 2025
Evaluating the Phytohormone Proficiencies of Multifarious Bacillus rugosus for Growth Promotion in Arachis hypogaea (L.)Aniruddh Rabari, Janki Ruparelia, Chaitanya Kumar Jha, et al.
Current Medicinal Chemistry|November 9, 2025
A Comprehensive Review on Promising Herbal Drug Discovery for Breast Cancer ManagementAdwitiya Banerjee, Shivnath Banerjee, Anil Kumar Singh, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Scientific Reports|August 19, 2025
Unlocking the antimalarial potential of novel steroid-tetraoxane hybrids through consensus molecular docking and molecular dynamics investigationDipankar Nath, Abhijit Debnath, Malita Sarma, et al.
Plos One|April 22, 2026
In search of novel PD1 inhibitor from natural products by high-throughput virtual screening and molecular dynamics simulationNeha Sharma, Abhijit Debnath, Rupa Mazumder, et al.
Bioorganic Chemistry|May 18, 2025
Design, synthesis, docking, DFT, and MD simulation studies of new piperazine, 1,3,4-oxadiazole, and quinoline conjugates: A search for potent antiepileptic agentsShrishti Tripathi, Rajnish Kumar, Abhijit Debnath, et al.
Bioorganic Chemistry|June 3, 2025
Corrigendum to "Design, synthesis, docking, DFT, and MD simulation studies of new piperazine, 1,3,4-oxadiazole, and quinoline conjugates: A search for potent antiepileptic agents" [Bioorg. Chem. 162 (2025) 108595]Shrishti Tripathi, Rajnish Kumar, Abhijit Debnath, et al.
Current Pharmaceutical Biotechnology|July 2, 2025
Challenges and Progress of Orphan Drug Development for Rare DiseasesAbhijit Debnath, Rupa Mazumder, Avijit Mazumder, et al.
Scientific Reports|August 28, 2025
Author Correction: Discovery of novel HBV core protein inhibitors by high throughput virtual screeningJahanvi Sanchitra, Abhijit Debnath, Anil Kumar Singh, et al.
Current Pharmaceutical Biotechnology|November 2, 2025
Novel Drug Molecules for Atherosclerosis from Ginkgo biloba, an Endangered Himalayan Herb, Via Pharmacoinformatics ApproachesShiwani Chahal, Abhijit Debnath, Pooja Ridhal, et al.
Scientific Reports|April 16, 2025
Discovery of novel HBV core protein inhibitors by high throughput virtual screeningJahanvi Sanchitra, Abhijit Debnath, Anil Kumar Singh, et al.
Journal of Basic Microbiology|April 3, 2025
Evaluating the Phytohormone Proficiencies of Multifarious Bacillus rugosus for Growth Promotion in Arachis hypogaea (L.)Aniruddh Rabari, Janki Ruparelia, Chaitanya Kumar Jha, et al.
Current Medicinal Chemistry|November 9, 2025
A Comprehensive Review on Promising Herbal Drug Discovery for Breast Cancer ManagementAdwitiya Banerjee, Shivnath Banerjee, Anil Kumar Singh, et al.
Pageof 5